Dr. Branagan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114Phone+1 617-726-2000
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2012
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2009 - 2010
Ben Gurion University of the NegevClass of 2009
Certifications & Licensure
CA State Medical License 2024 - 2026
MA State Medical License 2017 - 2024
MD State Medical License 2021 - 2024
NH State Medical License 2024 - 2024
PA State Medical License 2020 - 2024
NC State Medical License 2021 - 2023
ME State Medical License 2020 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients Start of enrollment: 2015 Sep 01
- A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients Start of enrollment: 2021 May 13
- ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy Start of enrollment: 2021 Nov 16
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 83 citationsConsensus treatment recommendations from the tenth International Workshop for Waldenström MacroglobulinaemiaJorge J. Castillo, Ranjana H. Advani, Andrew R. Branagan, Christian Buske, Meletios A. Dimopoulos
The Lancet. Haematology. 2020-11-01 - 10 citationsResponse and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy.Jorge J Castillo, Shayna R Sarosiek, Joshua N Gustine, Catherine A Flynn, Carly R Leventoff
Blood Advances. 2022-02-08 - 31 citationsEffect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, Jacob D Soumerai, Andrew J Yee
Blood Cancer Journal. 2022-11-01
Press Mentions
Patients with Multiple Myeloma and Waldenström Macroglobulinemia Have Impaired COVID-19 Vaccine ResponsivenessDecember 11th, 2021
Dr. Branagan on Tandem Transplants in Multiple MyelomaMarch 2nd, 2020
More Work Needed to Determine Best Treatment for High-Risk MyelomaFebruary 29th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
